ReviewPituitary2017
Acromegalic osteopathy.
Review in Pituitary, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 54 citations in OpenAlex.
- Bone and joint quality remains impaired in long-term controlled acromegaly: an HR-pQCT study.Journal of the Endocrine Society · 2026Article
- Consensus on acromegaly complications: an update.Pituitary · 2026Article
- Acromegaly treatment and bone: a bidirectional relationship.Pituitary · 2025Review
- Case Report: Bilateral lens dislocation as an atypical presentation of acromegaly and review of the ocular effects of GH/IGF-1 excess.Frontiers in endocrinology · 2025Review
- Novel approach to bone comorbidity in resistant acromegaly.Pituitary · 2024Review
- ACROMORFO study: gait analysis in a cohort of acromegalic patients.Journal of endocrinological investigation · 2024Article
- Craniofacial impact of acromegaly: when muscle ma-sse-tter.Pituitary · 2024Article
- The direct impact of pegvisomant on osteoblast functions and bone development.Journal of endocrinological investigation · 2024Article
- Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly.The Journal of clinical endocrinology and metabolism · 2023Article
- Acromegaly and Bone: An Update.Endocrinology and metabolism (Seoul, Korea) · 2023Review
- Increased Risk of Hip Fracture in Patients with Acromegaly: A Nationwide Cohort Study in Korea.Endocrinology and metabolism (Seoul, Korea) · 2023Article
- Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients?Endocrine · 2023Article
- Frequency of hyperostosis frontalis interna in patients with active acromegaly: is there a possible role of GH excess or hyperprolactinemia in its etiopathogenesis?Hormones (Athens, Greece) · 2023Article
- Vertebral Fractures in Acromegaly: A Systematic Review.Journal of clinical medicine · 2022Review
- Low sclerostin levels after long-term remission of acromegaly.Endocrine · 2022Article
- Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study.BMC geriatrics · 2021Article
- Trabecular bone score and bone mineral density in acromegalic osteopathy assessment: a cross-sectional study.Archives of osteoporosis · 2021Article
- Spine Bone Texture Assessed by Trabecular Bone Score in Active and Controlled Acromegaly: A Prospective Study.Journal of the Endocrine Society · 2021Article
- Review
- 3D DXA Hip Differences in Patients with Acromegaly or Adult Growth Hormone Deficiency.Journal of clinical medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acromegalic osteopathy is an emerging complication of acromegaly characterized by increase in bone turnover, deterioration in bone microarchitecture and high risk of vertebral fractures. Vertebral fractures, as diagnosed by a radiological and morphometric approach, occur in about one-third of acromegaly patients in close relationship with duration of active disease. However, the prediction of vertebral fractures in this clinical setting is still a matter of uncertainty, since the pathogenesis of acromegalic osteopathy is multifactorial and fractures may occur even in presence of normal bone mineral density. In this narrative article, we summarize the pathophysiology and clinical aspects of acromegalic osteopathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.